Lichen scrofulosorum following B.C.G.
D001500:BCG Vaccine / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D014382:Tuberculosis, Cutaneous / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology
D001500:BCG Vaccine; D007538:Isoniazid